Natural Product Research · 2015 · 47 citations · 6 references
MedicineMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyStructure-activity RelationshipsEnzyme InhibitionFungal BiochemistryOncology PharmacologyAnticancer ActivityAnticancer ChemotherapyAnticancer Compound ScreeningAnticancer Marine CompoundsAnticancer Mechanism Of ActionBioactive Fungal MetabolitesCancer Cell Proliferation InhibitionFungal Bioactive Compounds
The present work describes the anticancer activity of Ophiobolin A isolated from the endophytic fungus Bipolaris setariae. Ophiobolin A was isolated using preparative HPLC and its structure was confirmed by HRMS, (1)H NMR, (13)C NMR, COSY, DEPT, HSQC and HMBC. It inhibited solid and haematological cancer cell proliferation with IC50 of 0.4-4.3 μM. In comparison, IC50 against normal cells was 20.9 μM. It was found to inhibit the phosphorylation of S6 (IC50 = 1.9 ± 0.2 μM), ERK (IC50 = 0.28 ± 0.02 μM) and RB (IC50 = 1.42 ± 0.1 μM), the effector proteins of PI3K/mTOR, Ras/Raf/ERK and CDK/RB pathways, respectively. It induced apoptosis and inhibited cell cycle progression in MDA-MB-231 cancer cells with concomitant inhibition of signalling proteins. Thus, this study reveals that anticancer activity of Ophiobolin A is associated with simultaneous inhibition of multiple oncogenic signalling pathways namely PI3K/mTOR, Ras/Raf/ERK and CDK/RB.
6
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
Kathryn O’Reilly, F. Rojo, Qing‐Bai She et al. · Cancer Research · 2006 · 2.6K citations · Full text
Medicine, Oncology, Pharmacology +16
PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
Susan Wee, Zainab Jagani, Kay X. Xiang et al. · Cancer Research · 2009 · 455 citations
Targeting the RB-pathway in Cancer Therapy
Erik S. Knudsen, Jean Y. J. Wang · Clinical Cancer Research · 2010 · 205 citations · Full text
Medicine, Cancer Biology, Oncology +17